Synektik (WAR:SNT) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SNT Synektik SA WAR:SNT
89 GF Score
Price zł355.60
GF Value zł292.46
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Synektik Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WAR:SNT vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Synektik's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synektik Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Short Interest distribution charts can be found below:

* The bar in red indicates where Synektik's Short Interest falls into.


WAR:SNT
89GF Score
Synektik SA WAR:SNT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Synektik (WAR:SNT) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of zł355.60 is trading 21.6% above its estimated GF Value™ of zł292.46. GuruFocus considers Synektik to be Modestly Overvalued.

Key valuation signals for WAR:SNT:

  • Short Interest:
  • GF Value™: zł292.46 vs. price of zł355.60 (21.6% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the WAR:SNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synektik Business Description

Other Exchanges A2P:Germany
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
89GF Score

Get the complete analysis for WAR:SNT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł355.60
Price
zł292.46
GF Value